179 related articles for article (PubMed ID: 22615322)
1. Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.
Roestenberg M; de Vlas SJ; Nieman AE; Sauerwein RW; Hermsen CC
J Infect Dis; 2012 Aug; 206(3):319-23. PubMed ID: 22615322
[TBL] [Abstract][Full Text] [Related]
2. Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.
Sanderson F; Andrews L; Douglas AD; Hunt-Cooke A; Bejon P; Hill AV
Am J Trop Med Hyg; 2008 Jun; 78(6):878-83. PubMed ID: 18541763
[TBL] [Abstract][Full Text] [Related]
3. Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.
Hermsen CC; de Vlas SJ; van Gemert GJ; Telgt DS; Verhage DF; Sauerwein RW
Am J Trop Med Hyg; 2004 Aug; 71(2):196-201. PubMed ID: 15306710
[TBL] [Abstract][Full Text] [Related]
4. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.
Bijker EM; Bastiaens GJ; Teirlinck AC; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; Siebelink-Stoter R; Arens T; Teelen K; Nahrendorf W; Remarque EJ; Roeffen W; Jansens A; Zimmerman D; Vos M; van Schaijk BC; Wiersma J; van der Ven AJ; de Mast Q; van Lieshout L; Verweij JJ; Hermsen CC; Scholzen A; Sauerwein RW
Proc Natl Acad Sci U S A; 2013 May; 110(19):7862-7. PubMed ID: 23599283
[TBL] [Abstract][Full Text] [Related]
5. Protection against a malaria challenge by sporozoite inoculation.
Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
[TBL] [Abstract][Full Text] [Related]
6. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.
Hoffman SL; Goh LM; Luke TC; Schneider I; Le TP; Doolan DL; Sacci J; de la Vega P; Dowler M; Paul C; Gordon DM; Stoute JA; Church LW; Sedegah M; Heppner DG; Ballou WR; Richie TL
J Infect Dis; 2002 Apr; 185(8):1155-64. PubMed ID: 11930326
[TBL] [Abstract][Full Text] [Related]
7. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.
Epstein JE; Rao S; Williams F; Freilich D; Luke T; Sedegah M; de la Vega P; Sacci J; Richie TL; Hoffman SL
J Infect Dis; 2007 Jul; 196(1):145-54. PubMed ID: 17538895
[TBL] [Abstract][Full Text] [Related]
8. Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
Moorthy VS; Diggs C; Ferro S; Good MF; Herrera S; Hill AV; Imoukhuede EB; Kumar S; Loucq C; Marsh K; Ockenhouse CF; Richie TL; Sauerwein RW
Vaccine; 2009 Sep; 27(42):5719-25. PubMed ID: 19654061
[TBL] [Abstract][Full Text] [Related]
9. Mosquito production mooted as fast track to malaria vaccine.
Butler D
Nature; 2003 Oct; 425(6957):437. PubMed ID: 14523404
[No Abstract] [Full Text] [Related]
10. Pre-erythrocytic malaria vaccines: towards greater efficacy.
Hill AV
Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
12. Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection.
Walk J; van Gemert GJ; Graumans W; Sauerwein RW; Bijker EM
Am J Trop Med Hyg; 2018 Jun; 98(6):1705-1708. PubMed ID: 29714158
[TBL] [Abstract][Full Text] [Related]
13. A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.
Herrington DA; Clyde DF; Murphy JR; Baqar S; Levine MM; do Rosario V; Hollingdale MR
Trop Geogr Med; 1988 Apr; 40(2):124-7. PubMed ID: 3043855
[TBL] [Abstract][Full Text] [Related]
14. Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.
Vaughan JA; Scheller LF; Wirtz RA; Azad AF
Infect Immun; 1999 Aug; 67(8):4285-9. PubMed ID: 10417207
[TBL] [Abstract][Full Text] [Related]
15. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
16. Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.
Horii T; Shirai H; Jie L; Ishii KJ; Palacpac NQ; Tougan T; Hato M; Ohta N; Bobogare A; Arakaki N; Matsumoto Y; Namazue J; Ishikawa T; Ueda S; Takahashi M
Parasitol Int; 2010 Sep; 59(3):380-6. PubMed ID: 20493274
[TBL] [Abstract][Full Text] [Related]
17. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
[TBL] [Abstract][Full Text] [Related]
18. Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum.
Genton B; D'Acremont V; Lurati-Ruiz F; Verhage D; Audran R; Hermsen C; Wolters L; Reymond C; Spertini F; Sauerwein R
Vaccine; 2010 Sep; 28(40):6573-80. PubMed ID: 20691266
[TBL] [Abstract][Full Text] [Related]
19. Laboratory methods for the conduct of experimental malaria challenge of volunteers.
Davis JR
Vaccine; 1994 Mar; 12(4):321-7. PubMed ID: 8178554
[TBL] [Abstract][Full Text] [Related]
20. The Plasmodium sporozoite survives RTS,S vaccination.
Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
